Protein detail

SYNCI

Syncoilin (Syncoilin intermediate filament 1) (Syncoilin-1)

Entry name
SYNCI
UniProt ID
EVMP confidence score
0.38
Supporting publications (n)
1
Transmembrane count
Protein classification
Predicted intracellular proteins
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information11
Protein Names
Syncoilin (Syncoilin intermediate filament 1) (Syncoilin-1)
Protein Class
Predicted intracellular proteins
Protein Function
Predicted intracellular proteins
Entrez Gene Symbol
Gene Synonym (2)
SYNC1SYNCOILIN
Gene Description
Syncoilin, intermediate filament protein
Chromosome
1
Position
32679906-32703596
Supporting publications (n)
1
EVMP confidence score
0.38
Fluorescence & Localization1
Cell SpecificAstrocytes
Function & Pathway5
Relations & Evidence38

Ligand-Receptor Signaling (4)

4 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
intracellularintracellularComPPINoNoNoNoNo
intracellularintracellularGO_IntercellNoNoNoNoNo
intracellularintracellularUniProt_locationNoNoNoNoNo
intracellularintracellularOmniPathNoNoNoNoNo

Protein Complex Composition (33)

33 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
DESSYNCVIMP08670P17661Q9H7C40:0:0hu.MAP2
PRPHSYNCP41219Q9H7C40:0hu.MAP2
KRT23SYNCQ9C075Q9H7C40:0hu.MAP
Page 4 of 4Previous

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Mass spectrometryWestern blotting0
Sequence, Structure & Domains10

Sequences

Length
482
Mass
55,299
Sequence
MASPEPRRGGDGAAQAARKTRVEANSPLPKNSGSLNEAEALNPEVTLSSEGSLNLEDILYLEDTGDLDETLYVQETEKAEEALYIEEAMQPDEALHVEEPGNPEETVCVEETTEPDRIQFVEGPVEPGKPTSPEHVVYEGETVTRAEKSNPEESLRAEQSPSMEENLSIEDLELLEGRFQQCVQAVAQLEEERDQLIHELVLLREPALQEVQQVHQDILAAYKLHAQAELERDGLREEIRLVKQKLFKVTKECVAYQYQLECRQQDVAQFADFREVLTTRATQLSEELAQLRDAYQKQKEQLRQQLEAPPSQRDGHFLQESRRLSAQFENLMAESRQDLEEEYEPQFLRLLERKEAGTKALQRTQAEIQEMKEALRPLQAEARQLRLQNRNLEDQIALVRQKRDEEVQQYREQLEEMEERQRQLRNGVQLQQQKNKEMEQLRLSLAEELSTYKAMLLPKSLEQADAPTSQAGGMETQSQGAV
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=Q9H7C4-1; Sequence=Displayed; Name=2; IsoId=Q9H7C4-2; Sequence=VSP_039404
Alternative Sequence
454..482; AMLLPKSLEQADAPTSQAGGMETQSQGAV -> GCLEIYGQICNPETAKNFLAKDH (in isoform 2)

Domain & Motif Annotations

Compositional Bias
1..10; Basic and acidic residues; 144..156; Basic and acidic residues; 466..482; Polar residues
Domain (FT)
168..463; IF rod
Region
1..161; Head; 1..42; Disordered; 144..165; Disordered; 170..204; Coil 1A; 205..231; Linker 1; 232..309; Coil 1b; 310..349; Linker 2; 350..458; Coil 2; 459..482; Tail; 460..482; Disordered
Protein Families
Intermediate filament family
Sequence Similarities
Belongs to the intermediate filament family.
Clinical Relevance4
Interaction Protein
ENSG00000026025
Interaction Count
1
Interaction Dataset
intact_biogrid_opencell
Supporting Publications1
PMIDTitleAbstract
29045505Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.Proteomic analysis of the exosome 'surfaceome' revealed multiple PDAC-specific biomarker candidates: CLDN4, EPCAM, CD151, LGALS3BP, HIST2H2BE, and HIST2H2BF. Droplet digital PCR was used on 74 patients (136 total exosome samples) to determine baseline KRAS mutation call rates while patients were on therapy. KRAS mutations in total exosomes were detected in 44.1% of patients undergoing active therapy compared with 73.0% following exosome capture using the selected biomarkers.